MIAMI , Oct. 2, 2024 /PRNewswire/ -- eMerge Americas, the premier global technology conference + expo shaping the future of innovation, is thrilled to announce that Martine Rothblatt , PhD, JD, will return as a keynote speaker for eMerge Americas 2025 on March 27-28 in Miami, FL. Renowned for her pioneering work in biotechnology, artificial intelligence, and healthcare, Rothblatt has continued to revolutionize the healthtech space since her first appearance at eMerge Americas in 2015, making her return a highly anticipated highlight 10 years later at the 2025 event.
As the founder of Sirius Satellite Radio and founder + CEO of United Therapeutics, Rothblatt has been at the forefront of medical advancements, particularly in the treatment of pulmonary arterial hypertension (PAH). Her leadership has enabled the development of transformative therapies that have saved countless lives. Rothblatt's groundbreaking work in organ transplantation, specifically the use of genetically modified pig organs for human transplants, offers a potential solution to the global organ shortage crisis.
Additionally, her company's innovation in the 3D printing of lungs promises to radically alter the future of organ replacement and regenerative medicine. Her remarkable career has earned her numerous accolades, including being named one of Forbes' "100 Greatest Living Business Minds of the Past Century." Rothblatt has also been honored with prestigious awards such as the UCLA Medal—its highest honor�.
